Evidence map›Paper›PMID 34413966›Full record

ArticleJournal of healthcare engineering2021

Research Progress of Ferroptosis: A Bibliometrics and Visual Analysis Study.

Jian Xiong, Wenchuan Qi, Jiacheng Liu, Zhenqing Zhang, Ziwen Wang, Jinku Bao, Chuanfang Wu, Fanrong Liang

Open access · hybridAbstract read
In one paragraph

Article in Journal of healthcare engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Ferroptosis: A New Road towards Cancer Management.Molecules (Basel, Switzerland) · 2022
    Review
  9. Article
  10. The Research Landscape of Ferroptosis in Cancer: A Bibliometric Analysis.Frontiers in cell and developmental biology · 2022
    Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jian XiongChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID 0000-0002-8346-178X
Wenchuan QiChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID 0000-0002-3294-8870
Jiacheng LiuGuangxi University of Traditional Chinese Medicine, Nanning 530001, China.ORCID 0000-0003-3804-0836
Zhenqing ZhangGuangxi University of Traditional Chinese Medicine, Nanning 530001, China.ORCID 0000-0001-8017-5713
Ziwen WangChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID 0000-0002-5711-7774
Jinku BaoKey Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610041, China.ORCID 0000-0002-0096-7428
Chuanfang WuKey Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610041, China.ORCID 0000-0002-8363-5372
Fanrong LiangChengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID 0000-0003-3624-4528
Chengdu University of Traditional Chinese Medicine · CNGuangxi University of Chinese Medicine · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ferroptosis is a type of cell death with major topic of debate under current research and plays an important role in disease regulation. Objective: In this study, the literature management software Bibexcel and knowledge graph tool VOSviewer were used to summarize and analyze the international research trends and hotspots about ferroptosis in recent years, which highlight the disease mechanism, diagnosis, and treatment related to ferroptosis. Results: The research of ferroptosis started late and was formally proposed in 2012. It has developed rapidly and presented an "exponential" growth trend. China, the United States, Germany, Japan, and France are the main national forces of ferroptosis research development. The United States and China have a relatively high degree of support and attention to ferroptosis. Exploring oxidative stress, inducers/inhibitors, synergistic antitumor effect, relationships with other cell death types, GSH/GPX4 and iron metabolism imbalance related mechanisms of ferroptosis, and ferroptosis in the nervous system disease, ischemia-reperfusion injury, tumor, inflammation, and age-related diseases are the hot research directions. Conclusion: Ferroptosis has been a research hotspot in the field of biomedicine in recent years and has attracted the attention of scholars all over the world. The occurrence mechanism of ferroptosis and its application in neurological diseases, ischemia and reperfusion injury, tumors, inflammation, and aging are the hot directions of current research. In the future, ferroptosis can be appropriately considered for strengthening new approaches, new diseases, new inductors, new inhibitors, clinical transformation, and traditional medicine research.

Indexed as

FerroptosisNervous System DiseasesBibliometricsDatabases, FactualHumansPublicationsUnited States

Identifiers

PMID34413966
PMCPMC8370827
OpenAlexW3188638889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.